Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy
Clinical Drug Investigation · 2024
DOI: 10.1007/s40261-024-01366-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Martina Paoletti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy. mart.paoletti@…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Antibodies, Monoclonal, Humanized, Melanoma, Lung Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Roma Tor Vergata.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy. mart.paoletti@gmail.com.
- Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy.
- Institute for Leadership and Management in Health, Kingston University London, London, UK.
Förderung
- Università degli Studi di Roma Tor Vergata
Zitieren
APA
Paoletti, M., Bini, C., Marcellusi, A., & Mennini, F. S. (2024). Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01366-y
Vancouver
Paoletti M, Bini C, Marcellusi A, Mennini FS. Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01366-y
BibTeX
@article{Paoletti2024,
author = {Paoletti, Martina and Bini, Chiara and Marcellusi, Andrea and Mennini, Francesco Saverio},
title = {Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy},
journal = {Clinical Drug Investigation},
year = {2024},
doi = {10.1007/s40261-024-01366-y}
}
EUVIMED